WASHINGTON (AP) — The Food and Drug Administration announced Friday that it will overhaul packaging labels for the emergency contraceptive pill, Plan B, that women can take after having sex to prevent a pregnancy.
The federal agency said it will remove references on the contraception’s packaging that claim, without scientific evidence, that the pill prevents a fertilized egg from implanting in the womb.
The new labels are intended to further distinguish the emergency contraception — also known as the morning after pill — from abortion pills, which end a pregnancy after a fertilized egg has implanted in the lining of a woman’s uterus.
In a memo released Friday, the FDA clarified that taking Plan B pills is not the same as an abortion, a fact that has long been understood in the medical community.
“Evidence does not support that the drug affects implantation or maintenance of a pregnancy after implantation, therefore it does not terminate a pregnancy,” the FDA said in its statement.
